Last reviewed · How we verify
Matching Vehicle Solution
Matching Vehicle Solution is a pharmaceutical vehicle or excipient formulation designed to match the properties of an active pharmaceutical ingredient for comparative or control purposes in clinical trials.
At a glance
| Generic name | Matching Vehicle Solution |
|---|---|
| Sponsor | Meiji Seika Pharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
This product appears to be a placebo or vehicle control used in Phase 3 clinical trials, formulated to match the physical and chemical characteristics of an active drug without containing the therapeutic agent itself. It is used to enable blinded comparisons and establish the efficacy of the actual investigational drug by controlling for non-specific effects of the formulation.
Approved indications
Common side effects
Key clinical trials
- A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). (PHASE1, PHASE2)
- DBM-1152A Inhalation Solution in Chinese Healthy Subjects (PHASE1)
- DBM-1152A Inhalation Solution in Healthy Volunteers (PHASE1)
- Therapeutic Potential of Topical Latanoprost Acid in Hair Loss - Pilot, Proof-of-concept Study (NA)
- A-TANGO Phase 2 Study (PHASE2)
- A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease (PHASE1, PHASE2)
- Phase 1B/2 Clinical Trial Assessing the Safety, Tolerability and Preliminary Efficacy of the Intravenous Administration of Allogeneic Placental Mesenchymal Cells for the Preemptive Treatment of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery (PHASE1, PHASE2)
- To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |